Subtle biological changes linked to Alzheimer’s disease may begin as early as the late 50s — decades before memory loss or other symptoms appear — according to new research from Mayo Clinic. The study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association,
Disease
As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease and resulting liver scarring or cirrhosis also are rising. Patients often are diagnosed based on symptoms, such as gastrointestinal bleeding, fluid retention or jaundice, which happen when liver disease has progressed to a late stage. […]
Medcare has introduced a groundbreaking AI powered blood test, in response to the growing number of young people in the region having cardiovascular issues and sudden onset of heart attacks. Clinical studies show that in the MENA and South Asia regions, the average age for a first-time heart attack has decreases by 5-10 years. This […]
Eli Lilly and Company (NYSE: LLY) announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study showing that participants treated with Kisunla (donanemab-azbt) demonstrated slowing of decline, a benefit that continued to grow over three years compared to an untreated external cohort from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn’s disease. In this expert alert, Amanda Johnson, M.D., a gastroenterologist at Mayo Clinic, helps explain IBD and whether diet can help. People with IBD may experience persistent symptoms like frequent diarrhea, weight
QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models portfolio to include highly relevant and sophisticated models for metabolic dysfunction-associated steatohepatitis (MASH), ulcerative colitis (UC), wound healing, and
With immediate disbursement Saudi Arabia has reaffirmed its $500 million commitment to the Global Polio Eradication Initiative (GPEI), a critical step in the global effort to eradicate the disease and protect children worldwide. The announcement was made during the fourth Riyadh International Humanitarian Forum, where key global health leaders gathered to sign the
The Retina Clinic London will showcase cutting-edge innovations in the diagnosis, monitoring, and treatment of diabetic eye disease at Arab Health 2025, taking place at the Dubai World Trade Centre. Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ophthalmologist and vitreoretinal surgeon,
WHO faces funds’ shortage Yemen continues to bear the highest burden of cholera worldwide, with the country facing a persistent and severe outbreak that has ravaged its population for years. The outbreak is particularly devastating as Yemen struggles with an ongoing humanitarian crisis, further exacerbated by a lack of resources and damaged infrastructure. The
Neu REFIX Beta glucan, made in Japan has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (US FDA) for treatment of Duchenne muscular Dystrophy (DMD). These designations would help take the progress in pre-clinical and clinical studies conducted in Japan and India to clinical […]
WHO: Worrisome Global Trend A concerning new report reveals that almost one-third (31%) of adults worldwide, equating to approximately 1.8 billion individuals, failed to meet recommended physical activity levels in 2022. Published by the World Health Organization (WHO) in collaboration with academic researchers, the findings highlight a troubling rise in physical
Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, announced two-year results from the BIOADAPTOR Randomized Controlled (1:1) Trial (RCT), comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute OnyxTM Drug-Eluting Stent (DES) from 34 centers in Japan, Europe, and New Zealand. The results, for
Imperial College London Diabetes Centre (ICLDC), part of the M42 group, has become the first centre in Abu Dhabi to partner with bookdialysis, the leading online booking engine for holiday dialysis patients. ICLDC now joins a coveted network of top-tier clinics in more than 50 countries listed on the free booking platform, offering global travelers […]
To further highlight its commitment on improving patient outcomes in the Gulf, Pfizer hosted a media roundtable to raise awareness on Sickle Cell Disease (SCD) and revealed key findings from Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey conducted in several countries including GCC. Attended by leading healthcare professionals, the roundtable























